José Valentín
García Gutiérrez
Profesor/a Asociado/a en CC. de la Salud
Guy's Hospital
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Guy's Hospital (10)
2022
-
Breakthrough infections in MPN-COVID vaccinated patients
Blood Cancer Journal
-
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19
American Journal of Hematology
-
MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S326-S327
-
Second versus first wave of COVID-19 in patients with MPN
Leukemia
2021
-
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry
American Journal of Hematology, Vol. 96, Núm. 10, pp. 1186-1194
-
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Blood Cancer Journal, Vol. 11, Núm. 2
-
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
Leukemia, Vol. 35, Núm. 2, pp. 485-493
-
Long-term follow-up of recovered MPN patients with COVID-19
Blood Cancer Journal
2020
-
Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis
Blood Advances, Vol. 4, Núm. 22, pp. 5825-5835
2016
-
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
Haematologica, Vol. 101, Núm. 8, pp. 926-931